Thyroid News and Research

RSS

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.

27 Sep 2017

Researchers assess self-monitoring of blood glucose behavior among diabetes patients in China

Researchers in China who assessed self-monitoring of blood glucose behavior among nearly 19,000 patients with type 2 diabetes treated with oral medications reported very low SMBG rates both before and after the patients began treatment with basal insulin, although the data showed an increase in mean SMBG frequency after 6 months and the percentage of patients who never monitored their blood glucose decreased.

21 Sep 2017

Lower-than-normal TSH levels linked to increased risk of thyroid cancer

There is an increased risk of thyroid cancer associated with lower-than-normal thyroid hormone levels, a finding that could have a major impact on patients fighting the disease.

18 Sep 2017

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

An International Journal of Cancer study found that female survivors of certain types of cancer have higher risks of poor outcomes in pregnancies conceived after diagnosis than women without cancer.

12 Sep 2017

Researchers reveal new approach to precisely identify and treat prostate cancer

Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects.

7 Sep 2017

Researchers investigate link between thyroid hormone and red blood cell production

For more than a century, physicians have anecdotally noted that patients with an underactive thyroid - often caused by iodine deficiency - tended to also have anemia. But the link between thyroid hormone and red blood cell production has remained elusive.

6 Sep 2017

Scientists show how receptors for drugs act inside cells

G protein-coupled receptors are the key target of a large number of drugs. Würzburg scientists have now been able to show more precisely how these receptors act in the cell interior.

5 Sep 2017

Some thyroid cancer patients can safely delay surgery

Most people diagnosed with cancer want to start treatment as soon as possible, for fear that delaying care will allow their tumor to grow out of control.

31 Aug 2017

Sanford Health launches solid tumor oncolytic virus clinical trial

Sanford Health is the first site in the United States to launch a clinical trial using a genetically-engineered virus that aims to destroy therapy-resistant tumors.

17 Aug 2017

Timely diagnosis and treatment of carpal tunnel syndrome can prevent long-lasting damage

The sooner carpal tunnel syndrome is diagnosed and treated, the better the chances for symptom relief, according to experts at Hospital for Special Surgery in New York City.

4 Aug 2017

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization, recognized contributions to the field of nuclear medicine and molecular imaging during its 2017 Annual Meeting in Denver, Colorado. Several awards ceremonies were held to recognize the valuable role SNMMI members play in advancing the diagnosis and treatment of heart disease, cancer and neurological conditions.

2 Aug 2017

Adults with poor sleep patterns more likely to be overweight and obese, study finds

Adults in the UK who have poor sleep patterns are more likely to be overweight and obese and have poorer metabolic health, according to a new study.

27 Jul 2017

Study identifies potential treatment for fetal alcohol spectrum disorder

Two commonly used drugs erased the learning and memory deficits caused by fetal alcohol exposure when the drugs were given after birth, thus potentially identifying a treatment for the disorder, reports a new Northwestern Medicine study.

18 Jul 2017

Study: Impaired thyroid function may affect dialysis patients’ health and well-being

A new study indicates that impaired thyroid function may have detrimental effects on dialysis patients' health and well-being. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

13 Jul 2017

Nanolock-nanopore detects cancer driver mutations to facilitate early diagnosis, treatment

The moment when healthy cells turn into cancer cells is a critical point. And if caught early enough, many cancers can be stopped in their tracks.

7 Jul 2017

Novel technique to monitor nerve function could transform the way doctors perform surgeries

In a first-of-its-kind study, Mount Sinai researchers have discovered a novel technique to monitor laryngeal and vagus nerve function while patients are under anesthesia during otolaryngology and neurosurgery procedures.

3 Jul 2017

Study shows septic systems as important sources of emerging contaminants in drinking water

A new analysis shows that septic systems in the United States routinely discharge pharmaceuticals, consumer product chemicals, and other potentially hazardous chemicals into the environment.

27 Jun 2017

Cells key to blood vessel formation can also produce tumors and enable their spread

While it's widely held that tumors can produce blood vessels to support their growth, scientists now have evidence that cells key to blood vessel formation can also produce tumors and enable their spread.

20 Jun 2017

New guidelines for ultrasound-based risk stratification system to identify thyroid nodules that warrant biopsy

Nodules -- a type of abnormality detected by ultrasound -- are extremely common in the thyroid gland. Up to two-thirds of adults have nodules in this gland, and most are benign or only cause a slow-growing cancer that is no threat to life.

19 Jun 2017

'Mismatch repair' genetic defects drive cancer patient's response to immunotherapy drugs

In an expanded, three-year clinical trial of 86 patients with colorectal and 11 other kinds of cancer that have so-called 'mismatch repair' genetic defects, scientists at Johns Hopkins Medicine and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have found that half of the patients respond to an immunotherapy drug called pembrolizumab.

9 Jun 2017